• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » The top 5 MassDevice stories of the week — August 28, 2020

The top 5 MassDevice stories of the week — August 28, 2020

August 28, 2020 By Sean Whooley

MassDevice Top Five medtech stories weekAs earnings season concludes and the COVID-19 pandemic roars on, medtech companies continue to find new ways to make waves.

This week’s top five MassDevice stories showcase how companies are operating in the “new normal,” as they look toward the post-pandemic future, whenever that may arrive. Strong quarterly earnings, big funding rounds and new innovations in COVID-19 treatment comprise some of this week’s list.

Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five:

5. Medtronic’s recovery ‘faster than expected’ during Q1

Medtronic (NYSE:MDT) shares ticked up after the medtech giant came in well ahead of Wall Street projections for both earnings and revenues while posting profits of $491 million. Read the full story.

4. FDA clears Pelvital pelvic floor device

Pelvital announced that it received FDA clearance for its Flyte device, which is a first-of-its-kind, non-invasive, intravaginal home-use device designed to strengthen the pelvic floor muscles, which can help women with stress urinary incontinence. Read the full story.

3. iRhythm closes $220M offering

iRhythm Technologies (NSDQ:IRTC) closed an underwritten public offering worth proceeds of approximately $220 million, which it plans to put toward funding growth initiatives, as well as for working capital and other general corporate purposes. The company develops AI-based screening, diagnosis and management technology for atrial fibrillation. Read the full story.

2. Boston Scientific, Abbott listed among best workplaces for innovators

Fast Company’s “Best Workplaces for Innovators” in 2020 included the likes of Boston Scientific (NYSE:BSX) and Abbott (NYSE:ABT) within the top 20 of its list of 100 companies. Over 850 companies applied across more than 24 countries around the world for a slot in the innovative workplace rankings. Read the full story.

1. Abbott wins EUA for COVID-19 test that runs off a card

Abbott (NYSE:ABT) announced that its BinaxNow COVID-19 Ag Card — a speedy antigen test for the virus that can be directly read off the testing card — received FDA emergency use authorization (EUA). Abbott plans to ship tens of millions of tests in September, ramping to 50 million tests a month at the start of October. Read the full story.

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Regulatory/Compliance Tagged With: Abbott, Boston Scientific, coronavirus, COVID-19, iRhythm Technologies Inc., Medtronic, Pelvital, Top Five

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy